ACADIA Pharmaceuticals Inc. · San Diego, CA United States (NASDAQ: ACAD)
| 3911 Sorrento Valley Blvd. | Phone: 858-558-2871 |
| San Diego, CA | Fax: 858-558-2872 |
| 92121 | |
| United States | 
Map This Company |
ACADIA Pharmaceuticals Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
ACADIA Pharmaceuticals develops small molecule drugs for the treatment of central nervous system disorders. The biopharmaceutical company's most advanced compound, pimavanserin, is in clinical trials as a treatment for Parkinson's disease psychosis, which occurs in up to 40% of Parkinson's patients. Two other clinical-stage candidates are being developed in collaboration with
ACADIA Pharmaceuticals Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ACAD Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 27 |
Executives
37 executives listed for ACADIA Pharmaceuticals Inc.'s San Diego, CA location.
| Chairman and Director | Leslie Iversen | |
|---|---|---|
| CEO and Director | Uli Hacksell | |
| EVP, CFO, Chief Business Officer, and Treasurer | Thomas Aasen |